A business in context

MD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-10 · 0001193125-26-390731

  2. 4 · Ownership change

    Report date 2026-08-14 · 0001193125-26-355656

  3. 4 · Ownership change

    Report date 2026-08-12 · 0001193125-26-352534

  4. 4 · Ownership change

    Report date 2026-08-12 · 0001193125-26-352532

  5. 4 · Ownership change

    Report date 2026-08-12 · 0001193125-26-352531

  6. 4 · Ownership change

    Report date 2026-08-12 · 0001193125-26-352528

  7. 4 · Ownership change

    Report date 2026-08-12 · 0001193125-26-352527

  8. 4 · Ownership change

    Report date 2026-08-12 · 0001193125-26-352526

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-331513

  10. 8-K · Current report

    Report date 2026-08-04 · 0001193125-26-331488 · Items 2.02,9.01

  11. 8-K · Current report

    Report date 2026-07-21 · 0001193125-26-316225 · Items 5.02,7.01

  12. 8-K · Current report

    Report date 2026-07-15 · 0001193125-26-304033 · Items 2.02,7.01,9.01

  13. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-212117 · Items 5.02,5.07,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-204993

  15. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-204982 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-03-25 · 0001193125-26-127299

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-058074

  18. 8-K · Current report

    Report date 2026-02-19 · 0001193125-26-058063 · Items 2.02,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-261640

  20. 8-K · Current report

    Report date 2025-11-03 · 0001193125-25-261626 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-08-18 · 0000950170-25-109777 · Items 7.01,8.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-102382

  23. 8-K · Current report

    Report date 2025-08-05 · 0000950170-25-102375 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-07-01 · 0000950170-25-092261 · Items 5.02,7.01,9.01

  25. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-067076 · Items 5.07

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-063951

  27. 8-K · Current report

    Report date 2025-05-06 · 0000950170-25-063946 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-04-15 · 0000950170-25-055880 · Items 1.01

  29. DEF 14A · Proxy statement

    Report date 2025-03-26 · 0000950170-25-046327

  30. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-023730

  31. 8-K · Current report

    Report date 2025-02-20 · 0000950170-25-023723 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-01-12 · 0001193125-25-006190 · Items 5.02

  33. 8-K · Current report

    Report date 2025-01-13 · 0001193125-25-004937 · Items 2.02,7.01,9.01

  34. 8-K · Current report

    Report date 2024-11-29 · 0000950170-24-133723 · Items 5.02

  35. SC 13G · Ownership disclosure

    0001104659-24-117751

  36. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-119796

  37. 8-K · Current report

    Report date 2024-11-01 · 0000950170-24-119795 · Items 2.02,9.01

  38. SC 13G/A · Ownership disclosure

    0000354204-24-004672

  39. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-091193

  40. 8-K · Current report

    Report date 2024-08-01 · 0000950170-24-091185 · Items 2.02,5.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 8 transaction rows8AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

10 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-10
2026-09-14
Linynsky Laura AD · Disposition to issuer
Disposed
Common Stock6000.026.82
2026-08-14
2026-08-18
Young Sylvia JeanD · Disposition to issuer
Disposed
Common Stock18500.026.62
2026-08-12
2026-08-14
McEachin ThomasA · Grant / award
Acquired
Common Stock472.026.5
2026-08-12
2026-08-14
Weis Shirley AA · Grant / award
Acquired
Common Stock472.026.5
2026-08-12
2026-08-14
Starcher John M. Jr.A · Grant / award
Acquired
Common Stock472.026.5
2026-08-12
2026-08-14
Newman Kurt DouglasA · Grant / award
Acquired
Common Stock472.026.5
2026-08-12
2026-08-14
Linynsky Laura AA · Grant / award
Acquired
Common Stock472.026.5
2026-08-12
2026-08-14
Rucker Michael A.A · Grant / award
Acquired
Common Stock472.026.5
2026-08-12
2026-08-14
Young Sylvia JeanA · Grant / award
Acquired
Common Stock472.026.5
2026-08-12
2026-08-14
SANSONE GUY PA · Grant / award
Acquired
Common Stock472.026.5

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000893949Pediatrix Medical Group, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Pediatrix Medical Group · alias · wikidata
  • Mednax · alias · wikidata
  • MEDNAX, INC. · former SEC name · 2008-12-22 to 2022-06-21
  • PEDIATRIX MEDICAL GROUP INC · former SEC name · 1996-08-08 to 2009-01-02
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.01B$2.16B
2023-12-31$1.99B$2.21B
2022-12-31$1.97B$2.27B
2021-12-31$1.91B$2.38B
2020-12-31$1.73B$2.26B
2019-12-31$1.78B$2.35B
2018-12-31$1.72B$2.31B
2017-12-31$3.25B$4.47B

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗